For instance, very little is known about the case-by-case molecular heterogeneity among a specific tauopathy such as AD and how such heterogeneity would affect the underlying pathophysiological mechanisms such as tau propagation and seeding. The gene discussed is MAPT; the disease is Alzheimer disease.